The Court of Appeal has now delivered its judgment on the form of order following the successful appeal of Regeneron in Regeneron, Inc v Kymab Limited and Novo Nordisk A/S.  Amongst other consequential matters, in refusing permission to appeal to the Supreme Court, the judgment addresses the issues of a stay of a final injunction restraining Kymab from infringing the patents in suit pending any appeal and the delivery up and destruction of products produced by the claimed methods.  Links to the judgments of the Court of Appeal are to be found here http://www.bailii.org/ew/cases/EWCA/Civ/2018/671.pdf and here http://www.bailii.org/ew/cases/EWCA/Civ/2018/1186.html